{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:23:06Z","timestamp":1762431786628,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004351","name":"Sultan Qaboos University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejphar.2020.172960","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T11:08:22Z","timestamp":1580123302000},"page":"172960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats"],"prefix":"10.1016","volume":"873","author":[{"given":"Aly M.","family":"Abdelrahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhail","family":"Al Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuf","family":"Al Suleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ashique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadarsini","family":"Manoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badreldin H.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.172960_bib1","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s12272-001-2155-5","article-title":"Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats","volume":"31","author":"Abdelrahman","year":"2008","journal-title":"Arch Pharm. Res."},{"key":"10.1016\/j.ejphar.2020.172960_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.toxrep.2019.02.006","article-title":"Effect of levosimendan, an inodilator, on cisplatin-induced nephrotoxicity in rats","volume":"6","author":"Abdelrahman","year":"2019","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.ejphar.2020.172960_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00210-019-01655-w","article-title":"Effect of tocilizumab, an interleukin-6 inhibitor, on early stage streptozotocin-induced diabetic nephropathy in rats","volume":"392","author":"Abdelrahman","year":"2019","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172960_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/10641963.2015.1047947","article-title":"Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy","volume":"38","author":"Akhtar","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ejphar.2020.172960_bib5","first-page":"275","article-title":"Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl\/Rapp rats","volume":"62","author":"Biala","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172960_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2016.07.202","article-title":"Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper","volume":"222","author":"Farmakis","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2020.172960_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ejhf.9","article-title":"Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms","volume":"16","author":"Fedele","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2020.172960_bib8","first-page":"10","article-title":"Urinary markers of tubular injury in early diabetic nephropathy","author":"Fiseha","year":"2016","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.ejphar.2020.172960_bib9","first-page":"1","article-title":"The future: experimental therapies for renal disease in diabetes","volume":"26","author":"Fouli","year":"2018","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2020.172960_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0748233712451773","article-title":"Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats","volume":"30","author":"Gecit","year":"2014","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.ejphar.2020.172960_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.112.193961","article-title":"Levosimendan protection against kidney ischemia\/reperfusion injuries in anesthetized pigs","volume":"342","author":"Grossini","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.172960_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biopha.2017.07.095","article-title":"The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes","volume":"94","author":"Jaikumkao","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2020.172960_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1279250","article-title":"Approaches and methods to measure oxidative stress in clinical samples: research applications in the cancer field","volume":"2019","author":"Katerji","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2020.172960_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/IJNRD.S103784","article-title":"Rodent models of diabetic nephropathy: their utility and limitations","volume":"9","author":"Kitada","year":"2016","journal-title":"Int. J. Nephrol. Renovascular Dis."},{"key":"10.1016\/j.ejphar.2020.172960_bib15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbrc.2013.12.049","article-title":"Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes","volume":"443","author":"Kodera","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2020.172960_bib16","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.5114\/amsad.2019.86803","article-title":"The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure","volume":"22","author":"Korkmaz","year":"2019","journal-title":"Arch. Med. Sci. Atherosclerosis Dis."},{"key":"10.1016\/j.ejphar.2020.172960_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1160\/TH14-06-0549","article-title":"Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro","volume":"113","author":"Krychtiuk","year":"2015","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2020.172960_bib18","first-page":"110873","article-title":"Protective effects of Croton hookeri on streptozotocin-induced diabetic nephropathy","volume":"7","author":"Kundu","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2020.172960_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00592-007-0007-6","article-title":"Effect of TNF-a inhibition on urinary albumin excretion in experimental diabetic rats","volume":"44","author":"Moriwaki","year":"2007","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejphar.2020.172960_bib20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2004.01.073","article-title":"Effects of levosimendan on circulating proinflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure","volume":"93","author":"Parissis","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2020.172960_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2147\/TCRM.S188761","article-title":"Use of levosimendan in acute and advanced heart failure: short review on available real-world data","volume":"15","author":"Pashkovetsky","year":"2019","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ejphar.2020.172960_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2008050503","article-title":"Impaired tubular uptake explains albuminuria in early diabetic nephropathy","volume":"20","author":"Russo","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2020.172960_bib23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000101689.64849.97","article-title":"Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats","volume":"42","author":"Suganami","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2020.172960_bib24","doi-asserted-by":"crossref","first-page":"F333","DOI":"10.1152\/ajprenal.00285.2013","article-title":"Impaired renal function and development in Belgrade rats","volume":"306","author":"Veuthey","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2020.172960_bib25","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/DMSO.S217924","article-title":"Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy","volume":"12","author":"Wang","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.ejphar.2020.172960_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.metabol.2018.01.002","article-title":"IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice","volume":"83","author":"Wu","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2020.172960_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1510\/icvts.2007.161356","article-title":"The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study","volume":"7","author":"Yakut","year":"2008","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.ejphar.2020.172960_bib28","doi-asserted-by":"crossref","first-page":"116950","DOI":"10.1016\/j.lfs.2019.116950","article-title":"The effect of C-peptide on diabetic nephropathy: a review of molecular mechanisms","volume":"237","author":"Yaribeygi","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.172960_bib29","doi-asserted-by":"crossref","first-page":"F1453","DOI":"10.1152\/ajprenal.00485.2005","article-title":"Levosimendan protects against experimental endotoxemic acute renal failure","volume":"290","author":"Zager","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920300522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920300522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:35:30Z","timestamp":1757975730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920300522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":29,"alternative-id":["S0014299920300522"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.172960","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.172960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172960"}}